Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately respondin
about
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately respondin
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Phase III, multicentre, double ...... thritis inadequately respondin
@en
Phase III, multicentre, double ...... thritis inadequately respondin
@nl
type
label
Phase III, multicentre, double ...... thritis inadequately respondin
@en
Phase III, multicentre, double ...... thritis inadequately respondin
@nl
prefLabel
Phase III, multicentre, double ...... thritis inadequately respondin
@en
Phase III, multicentre, double ...... thritis inadequately respondin
@nl
P2093
P2860
P1476
Phase III, multicentre, double ...... thritis inadequately respondin
@en
P2093
Atsushi Hagino
Hiroaki Matsuno
Jiyoon Lee
Masato Tomomitsu
Seonghye Shin
Yeong Wook Song
P2860
P304
P356
10.1136/ANNRHEUMDIS-2017-212172
P407
P577
2017-12-19T00:00:00Z